ParkinsonFranceV1, PascalFrancis, Checkpoint, bibRecord, 001A16

Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study

Identifieur interne : 001A16 ( PascalFrancis/Checkpoint ); précédent : 001A15; suivant : 001A17

Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study

Auteurs : H. Allain ; F. Le Coz ; F. Goulley ; F. Brunet-Bourgin ; Y. Loria ; D. Bentue-Ferrer ; R. Decombe ; J.-M. Reymann ; P. Chaumet-Riffaud ; J.-M. Gandon

Source :

International journal of clinical pharmacology, therapy and toxicology : (1980) [ 0174-4879 ] ; 1991.

RBID : Pascal:91-0549078

Descripteurs français

Pascal (Inist)
- Antiparkinsonien, Stimulant dopaminergique, Association médicamenteuse, Forme pharmaceutique, Traitement, Chimiothérapie, Homme, Système nerveux pathologie, Récepteur dopaminergique D2, Forme libération contrôlée, Parkinson maladie, Essai thérapeutique contrôlé, Dopa, Bromocriptine, Essai clinique.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antiparkinson agent, Bromocryptine, Chemotherapy, Clinical trial, Controlled release form, Controlled therapeutic trial, D2 Dopamine receptor, Dopa, Dopamine agonist, Dosage form, Drug combination, Human, Nervous system diseases, Parkinson disease, Treatment.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 001B73
to stream PascalFrancis, to step Curation: 001478

Links to Exploration step

Pascal:91-0549078

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study</title>
<author><name sortKey="Allain, H" sort="Allain, H" uniqKey="Allain H" first="H." last="Allain">H. Allain</name>
</author>
<author><name sortKey="Le Coz, F" sort="Le Coz, F" uniqKey="Le Coz F" first="F." last="Le Coz">F. Le Coz</name>
</author>
<author><name sortKey="Goulley, F" sort="Goulley, F" uniqKey="Goulley F" first="F." last="Goulley">F. Goulley</name>
</author>
<author><name sortKey="Brunet Bourgin, F" sort="Brunet Bourgin, F" uniqKey="Brunet Bourgin F" first="F." last="Brunet-Bourgin">F. Brunet-Bourgin</name>
</author>
<author><name sortKey="Loria, Y" sort="Loria, Y" uniqKey="Loria Y" first="Y." last="Loria">Y. Loria</name>
</author>
<author><name sortKey="Bentue Ferrer, D" sort="Bentue Ferrer, D" uniqKey="Bentue Ferrer D" first="D." last="Bentue-Ferrer">D. Bentue-Ferrer</name>
</author>
<author><name sortKey="Decombe, R" sort="Decombe, R" uniqKey="Decombe R" first="R." last="Decombe">R. Decombe</name>
</author>
<author><name sortKey="Reymann, J M" sort="Reymann, J M" uniqKey="Reymann J" first="J.-M." last="Reymann">J.-M. Reymann</name>
</author>
<author><name sortKey="Chaumet Riffaud, P" sort="Chaumet Riffaud, P" uniqKey="Chaumet Riffaud P" first="P." last="Chaumet-Riffaud">P. Chaumet-Riffaud</name>
</author>
<author><name sortKey="Gandon, J M" sort="Gandon, J M" uniqKey="Gandon J" first="J.-M." last="Gandon">J.-M. Gandon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">91-0549078</idno>
<date when="1991">1991</date>
<idno type="stanalyst">PASCAL 91-0549078 INIST</idno>
<idno type="RBID">Pascal:91-0549078</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B73</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001478</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001A16</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001A16</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study</title>
<author><name sortKey="Allain, H" sort="Allain, H" uniqKey="Allain H" first="H." last="Allain">H. Allain</name>
</author>
<author><name sortKey="Le Coz, F" sort="Le Coz, F" uniqKey="Le Coz F" first="F." last="Le Coz">F. Le Coz</name>
</author>
<author><name sortKey="Goulley, F" sort="Goulley, F" uniqKey="Goulley F" first="F." last="Goulley">F. Goulley</name>
</author>
<author><name sortKey="Brunet Bourgin, F" sort="Brunet Bourgin, F" uniqKey="Brunet Bourgin F" first="F." last="Brunet-Bourgin">F. Brunet-Bourgin</name>
</author>
<author><name sortKey="Loria, Y" sort="Loria, Y" uniqKey="Loria Y" first="Y." last="Loria">Y. Loria</name>
</author>
<author><name sortKey="Bentue Ferrer, D" sort="Bentue Ferrer, D" uniqKey="Bentue Ferrer D" first="D." last="Bentue-Ferrer">D. Bentue-Ferrer</name>
</author>
<author><name sortKey="Decombe, R" sort="Decombe, R" uniqKey="Decombe R" first="R." last="Decombe">R. Decombe</name>
</author>
<author><name sortKey="Reymann, J M" sort="Reymann, J M" uniqKey="Reymann J" first="J.-M." last="Reymann">J.-M. Reymann</name>
</author>
<author><name sortKey="Chaumet Riffaud, P" sort="Chaumet Riffaud, P" uniqKey="Chaumet Riffaud P" first="P." last="Chaumet-Riffaud">P. Chaumet-Riffaud</name>
</author>
<author><name sortKey="Gandon, J M" sort="Gandon, J M" uniqKey="Gandon J" first="J.-M." last="Gandon">J.-M. Gandon</name>
</author>
</analytic>
<series><title level="j" type="main">International journal of clinical pharmacology, therapy and toxicology : (1980)</title>
<title level="j" type="abbreviated">Int. j. clin. pharmacol. ther. toxicol. : (1980)</title>
<idno type="ISSN">0174-4879</idno>
<imprint><date when="1991">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of clinical pharmacology, therapy and toxicology : (1980)</title>
<title level="j" type="abbreviated">Int. j. clin. pharmacol. ther. toxicol. : (1980)</title>
<idno type="ISSN">0174-4879</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Bromocryptine</term>
<term>Chemotherapy</term>
<term>Clinical trial</term>
<term>Controlled release form</term>
<term>Controlled therapeutic trial</term>
<term>D2 Dopamine receptor</term>
<term>Dopa</term>
<term>Dopamine agonist</term>
<term>Dosage form</term>
<term>Drug combination</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Stimulant dopaminergique</term>
<term>Association médicamenteuse</term>
<term>Forme pharmaceutique</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Homme</term>
<term>Système nerveux pathologie</term>
<term>Récepteur dopaminergique D2</term>
<term>Forme libération contrôlée</term>
<term>Parkinson maladie</term>
<term>Essai thérapeutique contrôlé</term>
<term>Dopa</term>
<term>Bromocriptine</term>
<term>Essai clinique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0174-4879</s0>
</fA01>
<fA02 i1="01"><s0>IJCPB5</s0>
</fA02>
<fA03 i2="1"><s0>Int. j. clin. pharmacol. ther. toxicol. : (1980)</s0>
</fA03>
<fA05><s2>29</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ALLAIN (H.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LE COZ (F.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GOULLEY (F.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BRUNET-BOURGIN (F.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LORIA (Y.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BENTUE-FERRER (D.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DECOMBE (R.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>REYMANN (J.-M.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CHAUMET-RIFFAUD (P.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>GANDON (J.-M.)</s1>
</fA11>
<fA14 i1="01"><s1>Univ. hosp., dep. neurology neuropharmacology</s1>
<s2>Rennes 35033</s2>
<s3>FRA</s3>
<sZ>A11011000</sZ>
</fA14>
<fA20><s1>314-322</s1>
</fA20>
<fA21><s1>1991</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15902</s2>
<s3>354000012495080050</s3>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>1 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>91-0549078</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>International journal of clinical pharmacology, therapy and toxicology : (1980)</s0>
</fA64>
<fA66 i1="01"><s0>DEU</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Stimulant dopaminergique</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Association médicamenteuse</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Forme pharmaceutique</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Traitement</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Forme libération contrôlée</s0>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Essai thérapeutique contrôlé</s0>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Dopa</s0>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Bromocriptine</s0>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Essai clinique</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dopamine agonist</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Drug combination</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dosage form</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Treatment</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Controlled release form</s0>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Controlled therapeutic trial</s0>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Dopa</s0>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Bromocryptine</s0>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Clinical trial</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Estimulante dopaminérgico</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Asociación medicamentosa</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Forma farmacéutica</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Forma liberación controlada</s0>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Ensayo terapéutico controlado</s0>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Dopa</s0>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Ensayo clínico</s0>
</fC03>
<fN21><s1>137</s1>
</fN21>
<fN82><s1>NIM</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list></list>
<tree><noCountry><name sortKey="Allain, H" sort="Allain, H" uniqKey="Allain H" first="H." last="Allain">H. Allain</name>
<name sortKey="Bentue Ferrer, D" sort="Bentue Ferrer, D" uniqKey="Bentue Ferrer D" first="D." last="Bentue-Ferrer">D. Bentue-Ferrer</name>
<name sortKey="Brunet Bourgin, F" sort="Brunet Bourgin, F" uniqKey="Brunet Bourgin F" first="F." last="Brunet-Bourgin">F. Brunet-Bourgin</name>
<name sortKey="Chaumet Riffaud, P" sort="Chaumet Riffaud, P" uniqKey="Chaumet Riffaud P" first="P." last="Chaumet-Riffaud">P. Chaumet-Riffaud</name>
<name sortKey="Decombe, R" sort="Decombe, R" uniqKey="Decombe R" first="R." last="Decombe">R. Decombe</name>
<name sortKey="Gandon, J M" sort="Gandon, J M" uniqKey="Gandon J" first="J.-M." last="Gandon">J.-M. Gandon</name>
<name sortKey="Goulley, F" sort="Goulley, F" uniqKey="Goulley F" first="F." last="Goulley">F. Goulley</name>
<name sortKey="Le Coz, F" sort="Le Coz, F" uniqKey="Le Coz F" first="F." last="Le Coz">F. Le Coz</name>
<name sortKey="Loria, Y" sort="Loria, Y" uniqKey="Loria Y" first="Y." last="Loria">Y. Loria</name>
<name sortKey="Reymann, J M" sort="Reymann, J M" uniqKey="Reymann J" first="J.-M." last="Reymann">J.-M. Reymann</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A16 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001A16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:91-0549078
   |texte=   Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study

Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians : a randomized double-lind crossover study

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri